{
    "organizations": [],
    "uuid": "7a38afe708b1acb261c41ab5f1ee4ff3b2a4e11e",
    "author": "",
    "url": "https://www.reuters.com/article/brief-cerus-chronic-anemia-phase-3-study/brief-cerus-chronic-anemia-phase-3-study-met-primary-efficacy-and-safety-endpoints-idUSFWN1PI18D",
    "ord_in_thread": 0,
    "title": "BRIEF-Cerus - Chronic Anemia Phase 3 Study Met Primary Efficacy And Safety Endpoints",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 22 PM / Updated 12 minutes ago BRIEF-Cerus - Chronic Anemia Phase 3 Study Met Primary Efficacy And Safety Endpoints Reuters Staff 1 Min Read \nJan 23 (Reuters) - Cerus Corp: \n* CERUS REPORTS POSITIVE TOP-LINE RESULTS FROM CHRONIC ANEMIA PHASE 3 STUDY EVALUATING INTERCEPT RED BLOOD CELLS IN THALASSEMIA PATIENTS \n* CERUS CORP - STUDY SUCCESSFULLY MET PRIMARY EFFICACY AND SAFETY ENDPOINTS \n* CERUS CORP - FULL RESULTS OF STUDY ARE PLANNED FOR SUBMISSION AND PRESENTATION AT UPCOMING SCIENTIFIC CONFERENCES AND FOR PUBLICATION Source text for Eikon: Further company coverage:",
    "published": "2018-01-23T23:21:00.000+02:00",
    "crawled": "2018-01-23T23:39:48.027+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "chronic",
        "anemia",
        "phase",
        "study",
        "met",
        "primary",
        "efficacy",
        "safety",
        "endpoint",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "cerus",
        "corp",
        "cerus",
        "report",
        "positive",
        "result",
        "chronic",
        "anemia",
        "phase",
        "study",
        "evaluating",
        "intercept",
        "red",
        "blood",
        "cell",
        "thalassemia",
        "patient",
        "cerus",
        "corp",
        "study",
        "successfully",
        "met",
        "primary",
        "efficacy",
        "safety",
        "endpoint",
        "cerus",
        "corp",
        "full",
        "result",
        "study",
        "planned",
        "submission",
        "presentation",
        "upcoming",
        "scientific",
        "conference",
        "publication",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}